What Every Prepared Patient Should Know About Vaccines
The Prepared Patient believes knowledge is the foundation of good health. Being prepared means walking into your doctor's office ready to have a real conversation. Few topics deserve that kind of preparation more than vaccines. They are among the most consequential tools in the history of medicine, and they are increasingly misunderstood. This newsletter is your guide to understanding what vaccines are, where they came from, how they are made safe, and why the choices we make today have profound consequences for our children and our most vulnerable neighbors.
A Brief History of Vaccines: From Cowpox to COVID
The story of vaccines begins in 1796 with an English physician named Edward Jenner. He observed that milkmaids who contracted cowpox seemed protected from the far deadlier smallpox. He tested this hypothesis, inoculated a young boy with cowpox material, and unknowingly laid the groundwork for modern immunology. The word "vaccine" itself derives from vacca, the Latin word for cow.
For nearly a century, vaccination remained a largely empirical practice. It worked, but scientists didn't fully understand why. That changed in the late 19th century when Louis Pasteur developed germ theory and created vaccines for cholera, anthrax, and rabies. By the early 20th century, vaccines existed for typhoid, plague, and diphtheria.
The mid-20th century brought breakthroughs that would transform pediatric medicine. Vaccines arrived for pertussis, tetanus, influenza, yellow fever, and, most dramatically, polio. Jonas Salk's inactivated polio vaccine was declared safe and effective in 1955, a moment celebrated across the U.S. as near-miraculous. Mass vaccination campaigns began to change the course of history.
By 1980, the World Health Organization declared smallpox eradicated. It remains the first and only human disease completely eliminated through vaccination. From Jenner's cowpox experiment to global eradication took less than 200 years.
Questions to ask your physician: Which vaccines have I received? Are my boosters current? What vaccines are recommended for my age group and health conditions?
The Diseases We Forgot, Why We Cannot Afford To
To understand why vaccines matter, you need to understand what they displaced.
Polio paralyzed tens of thousands of children every year in the United States alone. The 1952 epidemic left nearly 58,000 Americans infected, more than 3,000 dead, and over 21,000 with varying degrees of paralysis. Iron lungs filled hospital wards. Parents kept children away from swimming pools every summer out of fear. Today, polio is virtually unknown in the developed world, but it has not been eradicated globally. Vaccination rates are what stand between us and its return.
Measles, before the vaccine's introduction in 1963, infected 3 to 4 million Americans annually. Roughly 48,000 were hospitalized each year. About 1,000 suffered permanent brain damage, and 400 to 500 died. It was considered an almost universal childhood illness, and a dangerous one. Measles can suppress the immune system for months or even years after infection, a phenomenon called "immune amnesia," leaving children newly vulnerable to other diseases.
Diphtheria was once called the "strangling angel of children." A bacterial toxin that forms a leathery membrane in the throat, it killed 13,000 to 15,000 Americans annually in the early 20th century, the majority of them children under 15. Today it is nearly unheard of in vaccinated populations.
Whooping cough caused agonizing, prolonged coughing fits that could crack ribs and last for weeks. Before the vaccine, it killed thousands of infants each year in the United States alone. It remains one of the most common causes of vaccine-preventable death worldwide.
Haemophilus influenzae type b (HIB), known as Hib, was the leading cause of bacterial meningitis in children under five before its vaccine arrived in the late 1980s. It caused 20,000 serious infections and 1,000 deaths per year in the United States, and many survivors were left deaf or with lasting brain damage.
During my pediatrics training, I took care of many infants with HIB and streptococcus pneumonia blood infection and meningitis. Some died. Now these diseases are unheard of because of vaccines. But that could change if vaccination rates keep declining.
The Paradox of Success
Here is one of the most important concepts in public health, and one of the most dangerous misconceptions: vaccines are victims of their own success.
When diseases are suppressed to near-zero levels, people stop seeing them. Parents who have never witnessed a child gasping through whooping cough, or watched a teenager lose the use of their legs to polio, have no frame of reference. The disease feels theoretical. The reasoning becomes: why vaccinate against something that doesn't exist anymore?
The disease doesn't exist because of vaccination. That distinction matters enormously. Stop vaccinating, and the disease returns, not as a historical curiosity but as a genuine outbreak. This is not speculation. It has happened repeatedly and it is happening now.
In 2019, the United States recorded 1,282 measles cases, the highest count in 27 years, driven by unvaccinated communities. Polio re-emerged in New York in 2022, detected in wastewater, with a confirmed paralytic case. The UK lost its measles-eliminated status in 2018 after vaccination rates fell.
Many dangerous diseases persist in animal reservoirs, in unvaccinated populations around the world, and in travelers crossing borders every day. High vaccination rates are what epidemiologists call herd immunity, and it is the only thing keeping these diseases from gaining a foothold again.
Questions to ask your physician: What diseases are circulating in my community right now? What is the current measles vaccination rate in my county? What would happen if my child missed their MMR vaccine?
How New Vaccines Are Developed and Approved
Vaccine development is one of the most rigorous scientific processes in medicine.
It begins in the laboratory. Scientists identify antigens, the parts of a pathogen that trigger an immune response, and test candidate formulations in cell cultures and animal models. This phase can take years and filters out the vast majority of candidates before any human exposure occurs.
Phase 1 clinical trials involve a small number of healthy volunteers, typically 20 to 100. The primary goal is safety. Researchers assess how the body responds, identify any adverse effects, and begin establishing appropriate dosing. These trials are carefully monitored and dose-escalated.
Phase 2 trials expand to hundreds of participants, including the age groups the vaccine is intended for. Researchers continue evaluating safety and begin assessing whether the vaccine produces a meaningful immune response.
Phase 3 trials are large-scale efficacy studies involving thousands to tens of thousands of participants across diverse populations and geographies. They are typically randomized and placebo-controlled, the gold standard of medical evidence. These trials measure whether the vaccine actually prevents disease and continue monitoring for adverse events at population scale.
In the United States, the FDA evaluates every aspect of the manufacturing process, clinical data, and proposed labeling before granting approval. This review is independent of the scientists who developed the vaccine. After approval, multiple surveillance systems monitor real-world outcomes in millions of recipients, allowing detection of even rare adverse events that may not have appeared in trials.
The mRNA vaccines developed for COVID-19 moved faster than traditional timelines. They did so by running trial phases concurrently, with the financial risk borne upfront, and by leveraging existing mRNA research infrastructure developed over decades. The evidentiary requirements were the same. The speed came from investment and coordination, not from cutting corners.
Questions to ask your physician: Where can I find the clinical trial data for a vaccine I am considering? What does Emergency Use Authorization mean versus full approval?
How Vaccine Safety Is Monitored and Ensured
No medical intervention is without risk. Vaccines are no exception. The Prepared Patient asks about benefits and risks, and the data on vaccines is more extensive than for almost any other medical product.
Pre-approval safety monitoring across all clinical trial phases involves active, systematic tracking of every reported symptom, adverse event, and lab abnormality. Independent Data Safety Monitoring Boards review accumulating data during trials and can halt a study immediately if a safety signal emerges.
After approval, multiple systems work in parallel. VAERS, the Vaccine Adverse Event Reporting System, is a national reporting system that anyone, patients, parents, or providers, can use to report an adverse event following vaccination. It is a signal-detection tool. A reported event does not confirm that the vaccine caused it, but unusual patterns trigger formal investigation.
The Vaccine Safety Datalink links electronic health records from millions of patients to monitor for vaccine-associated outcomes in near real-time. When a safety question arises, the Biologics Effectiveness and Safety system uses large healthcare databases to conduct rapid studies. Internationally, the WHO's Global Advisory Committee on Vaccine Safety ensures that signals detected in any country are shared and evaluated across borders.
These systems have worked. The original Rotashield rotavirus vaccine was pulled from the market in 1999 after surveillance detected a rare association with intussusception, a type of bowel obstruction. The rare myocarditis signal observed in young males after mRNA COVID vaccines was identified, investigated, and incorporated into clinical guidance. The safety infrastructure functioned as designed.
Questions to ask your physician: What are the most common side effects of this vaccine? What rare risks exist, and how do they compare to the risks of the disease itself? What should I watch for after my child is vaccinated?
Declining Vaccination Rates and What Comes Next
After decades of progress, vaccination rates in the United States and globally are falling. The consequences are already visible.
The CDC reported that in the 2022 to 2023 school year, kindergarten vaccination coverage for measles, mumps, and rubella dropped to 93.1 percent, below the 95 percent threshold needed for herd immunity. In seven states, coverage fell below 90 percent. Exemption rates hit a record high.
Children too young to be vaccinated depend entirely on the immunity of those around them. Infants under 12 months cannot receive the MMR vaccine. A two-month-old in a community with low vaccination rates faces measles exposure with no personal protection available.
Immunocompromised individuals face the same vulnerability. People undergoing chemotherapy, living with HIV, or taking immunosuppressive drugs for autoimmune conditions often cannot mount a full immune response to vaccines, or cannot receive certain live-virus vaccines at all. Their safety depends on community immunity. When vaccination rates fall, these individuals pay the steepest price.
The resurgence is already underway. Measles outbreaks have occurred in multiple U.S. states in recent years, concentrated in under-vaccinated communities. Global measles deaths rose 43 percent between 2016 and 2022. Whooping cough cases have climbed steadily. Outbreaks tracked in 2024 and 2025 appeared in communities across multiple continents that had previously been considered well-protected.
Misinformation is a significant driver of this trend. Research consistently shows that parental vaccine hesitancy is fueled by online misinformation and a deep distrust of institutions, compounded by the fact that most parents today have never seen the diseases vaccines prevent. The most widely cited claim fueling MMR hesitancy, a purported link between the vaccine and autism, originated from a 1998 paper that was found to be fraudulent, retracted, and whose author lost his medical license. Dozens of large-scale studies involving millions of children have found no such link.
What Can The Prepared Patient Do?
Verify your vaccination records and those of your children with your physician. Ask specifically about vaccination rates in your child's school or local community. Bring your concerns to your doctor directly, not for reassurance, but for accurate, individualized guidance. And recognize that vaccination is not only a personal health decision. It is a decision that affects the people around you who cannot protect themselves.
Final Thought: The Prepared Patient Asks, Listens, and Acts
The prepared patient is not someone who avoids hard questions. The prepared patient asks better ones.
Vaccines have an extraordinary track record, built over more than two centuries, of preventing suffering and saving lives. There is real nuance in the details of specific vaccines, specific populations, and specific medical histories. Those conversations are worth having with your physician.
Verify your records. Update what needs updating. Ask your doctor which vaccines are right for you and your family. That is what being prepared looks like.
The Prepared Patient A newsletter dedicated to helping patients become active, informed participants in their own healthcare. Topics include chronic disease management, navigating the healthcare system, understanding medical evidence, and building a productive relationship with your care team.
This newsletter is for educational purposes and does not constitute medical advice. Please consult your physician for guidance specific to your health situation.